Bullous pemphigoid triggered by COVID ‐19 vaccine: Rapid resolution with corticosteroid therapy

Volume: 35, Issue: 1
Published: Nov 30, 2021
Abstract
Bullous pemphigoid (BP) is an acquired autoimmune blistering disease characterized by autoantibodies against basement membrane zone antigens. Several trigger factors have been identified for this disorder, such drugs, ultraviolet radiation, trauma and burns. Pemphigoid cases have been reported in association with vaccination, including rabies,1 influenza, pnuemococcus, tetanus, diphtheria,2 pertussis, poliomyelitis Heaemophilus influenzae B,...
Paper Details
Title
Bullous pemphigoid triggered by COVID ‐19 vaccine: Rapid resolution with corticosteroid therapy
Published Date
Nov 30, 2021
Volume
35
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.